GFAP and Alzheimer disease: Plasma biomarkers, like p-tau217, Aβ42, and GFAP, have been widely studied for AD diagnostics,31 and the spectra of purified biomarkers have been used to derive spectral reference libraries for traumatic brain injury in a previous study.32